Distal radius fractures wrist fractures
Conditions
Interventions
The study group will receive a axillary nerve block using 30ml (300 mg)
prilocaine. The control group will receive a cubital nerve block using 20ml
(200 mg) prilocaine.
Sponsors
Reinier de Graaf Groep
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Proven dislocated distal radius (simple or multifragmentary, intra-articular or extra-articular fractures) requiring closed reduction Normal upper extremity anatomy and neurovascular examination Aged 18-years or older Patients eligible for primary surgical fracture fixation
Exclusion criteria
Exclusion criteria: Inability to perform the NRS for pain (eg due to delirium, or cognitive impairment) No good understanding of the Dutch language Multi-trauma patients Hypersensitivity to prilocaine and/or PABA (preservative agent in Citanest) Methemoglobinaemie
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objectives of this study are to investigate whether axillary nerve block leads to a decrease in pain compared to control patients. This will be measured through a raw pain intensity difference (PID) using visual analogue pain score after fracture reduction. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary parameters of this study includes pain measured in rest, during physical examination, after the analgesia procedure, after fracture reduction, after plaster cast application, after control radiograph, secondary loss of reduction measured on plain radiographs. | — |
Countries
Netherlands
Outcome results
None listed